EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immune cells and checkpoints in pancreatic adenocarcinoma: Association with clinical and pathological characteristics

Maria Auxiliadora de Paula Carneiro Cysneiros iD, Magno Belém Cirqueira, Lucas de Figueiredo Barbosa iD, Ênio Chaves de Oliveira, Lucio Kenny Morais, Isabela Jubé Wastowski, Vitor Gonçalves Floriano

PLOS ONE · 02.07.2024 · 19 (7) · e0305648

DOI: 10.1371/journal.pone.0305648 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 02.07.2024. Verfasst von Maria Auxiliadora de Paula Carneiro Cysneiros und 6 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostic and Therapeutic Support Division of Clinical Hospital, Federal University of Goias, Goiania, Brazil. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Adenocarcinoma, Tumor Microenvironment, B7-H1 Antigen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pancreatic adenocarcinoma is an extremely aggressive neoplasm, with many challenges to be overcome in order to achieve a truly effective treatment. It is characterized by a mostly immunosuppressed environment, with dysfunctional immune cells and active immunoinhibitory pathways that favor tumor evasion and progression. Thus, the study and understanding of the tumor microenvironment and the various cells subtypes and their functional capacities are essential to achieve more effective treatments, especially with the use of new immunotherapeutics.

Methods

Seventy cases of pancreatic adenocarcinoma divided into two groups 43 with resectable disease and 27 with unresectable disease were analyzed using immunohistochemical methods regarding the expression of programmed cell death ligand 1 (PD-L1), programmed cell death ligand 2 (PD-L2), and human leukocyte antigen G (HLA-G) molecules as well as the populations of CD4+ and CD8+ T lymphocytes, regulatory T cells (Tregs), and M2 macrophages (MM2). Several statistical tests, including multivariate analyses, were performed to examine how those immune cells and immunoinhibitory molecules impact the evolution and prognosis of pancreatic adenocarcinoma.

Results

CD8+ T lymphocytes and M2 macrophages predominated in the group operated on, and PD-L2 expression predominated in the unresectable group. PD-L2 was associated with T stage, lymph node metastasis, and clinical staging, while in survival analysis, PD-L2 and HLA-G were associated with a shorter survival. In the inoperable cases, Tregs cells, MM2, PD-L1, PD-L2, and HLA-G were positively correlated.

Conclusions

PD-L2 and HLA-G expression correlated with worse survival in the cases studied. Tumor microenvironment was characterized by a tolerant and immunosuppressed pattern, mainly in unresectable lesions, where a broad positive influence was observed between immunoinhibitory cells and immune checkpoint proteins expressed by tumor cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsAdenocarcinomaTumor MicroenvironmentB7-H1 AntigenHLA-G AntigensHumansMaleFemaleMiddle AgedAgedProgrammed Cell Death 1 Ligand 2 ProteinPrognosisCD8-Positive T-LymphocytesAdultT-Lymphocytes, RegulatoryAged, 80 and overMacrophages

Substanzen

B7-H1 AntigenHLA-G AntigensCD274 protein, humanProgrammed Cell Death 1 Ligand 2 ProteinPDCD1LG2 protein, human

Autor:innen und Institutionen

  • Diagnostic and Therapeutic Support Division of Clinical Hospital, Federal University of Goias, Goiania, Brazil.
  • Pathology Department, Federal University of São Paulo, São Paulo, Brazil.
  • Surgery Department of Medicine College, Federal University of Goias, Goiania, Brazil.
  • Biological Sciences and Health Institute, State University of Goias, Goiania, Brazil.
  • Clinics Department of Medicine College, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

ORCID-Profile: Maria Auxiliadora de Paula Carneiro Cysneiros, Lucas de Figueiredo Barbosa

Zitieren

APA

Cysneiros, M. A. P. C., Cirqueira, M. B., Barbosa, L. F., Chaves de Oliveira, Ê., Morais, L. K., Wastowski, I. J., & Floriano, V. G. (2024). Immune cells and checkpoints in pancreatic adenocarcinoma: Association with clinical and pathological characteristics. PLOS ONE, 19(7), e0305648. https://doi.org/10.1371/journal.pone.0305648

Vancouver

Cysneiros MAPC, Cirqueira MB, Barbosa LF, Chaves de Oliveira Ê, Morais LK, Wastowski IJ, et al. Immune cells and checkpoints in pancreatic adenocarcinoma: Association with clinical and pathological characteristics. PLOS ONE. 2024;19(7):e0305648. doi:10.1371/journal.pone.0305648

BibTeX
@article{Cysneiros2024,
  author = {Cysneiros, Maria Auxiliadora de Paula Carneiro and Cirqueira, Magno Belém and Barbosa, Lucas de Figueiredo and Chaves de Oliveira, Ênio and Morais, Lucio Kenny and Wastowski, Isabela Jubé and Floriano, Vitor Gonçalves},
  title = {Immune cells and checkpoints in pancreatic adenocarcinoma: Association with clinical and pathological characteristics},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {7},
  pages = {e0305648},
  doi = {10.1371/journal.pone.0305648}
}
Kostenlos starten →